Recordati Rare Diseases
Chiara Gargiulo is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as General Manager for Italy and Greece at Recordati Rare Diseases since November 2022. Prior roles include Vice President of Business Unit RIA at AstraZeneca and various managerial positions at AbbVie, focusing on Rheumatology and Gastroenterology. Chiara also led the launch of Daklinza at Bristol-Myers Squibb and held marketing roles at Abbott and Procter & Gamble. Academic credentials include a degree from Sapienza Università di Roma, obtained between 1992 and 1998.
This person is not in any offices
Recordati Rare Diseases
3 followers
Recordati Rare Diseases is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990, Recordati Rare Diseases is one of the most active companies in the field of rare diseases.